AstraZeneca expects ‘next generation’ COVID-19 vaccine

Tackle variants by autumn

 AstraZeneca and Oxford University aim to produce the next generation of COVID-19 vaccines that will protect against variants as soon as the autumn, a senior executive at the British drugmaker said on Wednesday.

Asked when AstraZeneca could produce a next generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said “as rapidly as possible”.

“We’re working very hard and we’re already talking about not just the variants that we have to make in laboratories, but also the clinical studies that we need to run,” he said in a briefing with media.

Comments are closed.